Palisade Capital Management LLC Heron Therapeutics, Inc. Transaction History

Palisade Capital Management LLC

$3.26 Billion
Q1 2024

A detailed history of Palisade Capital Management LLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Palisade Capital Management LLC holds 3,732,241 shares of HRTX stock, worth $11 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

3,732,241

Previous 3,646,103 2.36%

Holding current value

$11 Million

Previous $6.2 Million 66.8%

% of portfolio

0.32%

Previous 0.19%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.71 - $3.06 $147,295 - $263,582	86,138 Added 2.36%	3,732,241 $10.3 Million
Q4 2023 Feb 14, 2024	SELL	$0.54 - $1.82 $251,017 - $846,023	-464,848 Reduced 11.31%	3,646,103 $6.2 Million
Q3 2023 Nov 14, 2023	SELL	$0.97 - $1.8 $31,717 - $58,856	-32,698 Reduced 0.79%	4,110,951 $4.23 Million
Q2 2023 Aug 14, 2023	BUY	$1.11 - $2.88 $192,432 - $499,285	173,363 Added 4.37%	4,143,649 $4.81 Million
Q1 2023 May 08, 2023	BUY	$1.51 - $3.25 $278,430 - $599,270	184,391 Added 4.87%	3,970,286 $6 Million

Q4 2022 Feb 14, 2023	BUY	$2.25 - $4.67 $893,841 - $1.86 Million	397,263 Added 11.72%	3,785,895 $9.46 Million
Q3 2022 Nov 14, 2022	BUY	$2.66 - $5.37 $1.13 Million - $2.28 Million	424,558 Added 14.32%	3,388,632 $14.3 Million
Q2 2022 Aug 10, 2022	BUY	$2.3 - $6.29 $98,824 - $270,262	42,967 Added 1.47%	2,964,074 $8.27 Million
Q1 2022 May 09, 2022	SELL	$4.63 - $9.94 $523,490 - $1.12 Million	-113,065 Reduced 3.73%	2,921,107 $16.7 Million
Q4 2021 Feb 10, 2022	BUY	$8.35 - $12.6 $4.53 Million - $6.84 Million	542,589 Added 21.78%	3,034,172 $27.7 Million
Q3 2021 Nov 15, 2021	BUY	$10.13 - $15.0 $6.81 Million - $10.1 Million	672,452 Added 36.97%	2,491,583 $26.6 Million
Q2 2021 Aug 12, 2021	BUY	$13.27 - $18.48 $10 Million - $14 Million	755,397 Added 71.01%	1,819,131 $28.2 Million
Q1 2021 May 12, 2021	BUY	$14.49 - $20.72 $2.51 Million - $3.59 Million	173,116 Added 19.44%	1,063,734 $17.2 Million
Q4 2020 Feb 11, 2021	BUY	$14.61 - $22.14 $1.02 Million - $1.55 Million	70,079 Added 8.54%	890,618 $18.9 Million
Q3 2020 Nov 12, 2020	BUY	$13.67 - $17.77 $1.98 Million - $2.58 Million	145,174 Added 21.5%	820,539 $12.2 Million
Q2 2020 Aug 06, 2020	BUY	$10.89 - $21.47 $55,833 - $110,076	5,127 Added 0.76%	675,365 $9.94 Million
Q1 2020 May 13, 2020	BUY	$10.23 - $24.56 $767,659 - $1.84 Million	75,040 Added 12.61%	670,238 $7.87 Million
Q4 2019 Feb 04, 2020	BUY	$17.42 - $26.61 $947,282 - $1.45 Million	54,379 Added 10.05%	595,198 $14 Million
Q3 2019 Nov 06, 2019	BUY	$16.36 - $21.39 $546,391 - $714,383	33,398 Added 6.58%	540,819 $10 Million
Q2 2019 Aug 06, 2019	BUY	$16.93 - $26.22 $2.08 Million - $3.22 Million	122,680 Added 31.89%	507,421 $9.43 Million
Q1 2019 May 13, 2019	BUY	$23.15 - $28.34 $1.88 Million - $2.3 Million	81,135 Added 26.72%	384,741 $9.4 Million
Q4 2018 Feb 12, 2019	BUY	$22.03 - $32.01 $6.69 Million - $9.72 Million	303,606 New	303,606 $7.88 Million

Others Institutions Holding HRTX

# of Institutions

168

Shares Held

119M

Call Options Held

151K

Put Options Held

103K

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $349M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Palisade Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Palisade Capital Management LLC with notifications on news.

Account

Palisade Capital Management LLC Heron Therapeutics, Inc. Transaction History